Company or ticker...

Tango Therapeutics

Tango develops targeted cancer medicines using synthetic lethality biology.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

TNGX

5.1B

79.9

n/a

255.59%

Key Facts

M. Cap

PS

PE

YTD

5.1B

79.9

n/a

255.59%

10MA

20MA

50MA

200MA

$TNGX